ERBB2/HOXB13 co-amplification with interstitial loss of BRCA1 defines a unique subset of breast cancers
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
ERBB2/HOXB13 co-amplification with interstitial loss of BRCA1 defines a unique subset of breast cancers ; volume:26 ; number:1 ; day:18 ; month:12 ; year:2024 ; pages:1-15 ; date:12.2024
Breast cancer research ; 26, Heft 1 (18.12.2024), 1-15, 12.2024
- Creator
-
Mitsiades, Irene Rin
Onozato, Maristela
Iafrate, A. John
Hicks, Daniel
Gülhan, Doğa C.
Sgroi, Dennis C.
Rheinbay, Esther
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13058-024-01943-1
- URN
-
urn:nbn:de:101:1-2503010637400.240813224596
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mitsiades, Irene Rin
- Onozato, Maristela
- Iafrate, A. John
- Hicks, Daniel
- Gülhan, Doğa C.
- Sgroi, Dennis C.
- Rheinbay, Esther
- SpringerLink (Online service)
Other Objects (12)
Loss of the PTCH1 tumor suppressor defines a new subset of plexiform fibromyxoma
Dysregulation of a specific immune-related network of genes biologically defines a subset of schizophrenia
Trastuzumab Deruxtecan-Induced Interstitial Lung Disease/Pneumonitis in ERBB2-Positive Advanced Solid Malignancies: A Systematic Review
Downregulation of miR-204 expression defines a highly aggressive subset of Group 3/Group 4 medulloblastomas
Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancer
Expression of leukosialin (CD43) defines a major intrahepatic T cell subset associated with protective responses in visceral leishmaniasis
miR-1296-5p decreases ERBB2 expression to inhibit the cell proliferation in ERBB2-positive breast cancer
Genetische Analyse des Tyrosinkinase-Rezeptors ErbB2
Genome profiling of ERBB2-amplified breast cancers
Genetische Analyse des Tyrosinkinase-Rezeptors ErbB2
A FERM-adjacent (FA) region defines a subset of the 4.1 superfamily and is a potential regulator of FERM domain function
In vivo pharmacological profiling in Xenopus embryos defines a subset of A1 adenosine receptor-selective antagonists with potent anti-angiogenic activities
Loss of the PTCH1 tumor suppressor defines a new subset of plexiform fibromyxoma
Dysregulation of a specific immune-related network of genes biologically defines a subset of schizophrenia
Trastuzumab Deruxtecan-Induced Interstitial Lung Disease/Pneumonitis in ERBB2-Positive Advanced Solid Malignancies: A Systematic Review
Downregulation of miR-204 expression defines a highly aggressive subset of Group 3/Group 4 medulloblastomas
Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancer
Expression of leukosialin (CD43) defines a major intrahepatic T cell subset associated with protective responses in visceral leishmaniasis
miR-1296-5p decreases ERBB2 expression to inhibit the cell proliferation in ERBB2-positive breast cancer
Genetische Analyse des Tyrosinkinase-Rezeptors ErbB2
Genome profiling of ERBB2-amplified breast cancers
Genetische Analyse des Tyrosinkinase-Rezeptors ErbB2
A FERM-adjacent (FA) region defines a subset of the 4.1 superfamily and is a potential regulator of FERM domain function
In vivo pharmacological profiling in Xenopus embryos defines a subset of A1 adenosine receptor-selective antagonists with potent anti-angiogenic activities
Loss of the PTCH1 tumor suppressor defines a new subset of plexiform fibromyxoma
Dysregulation of a specific immune-related network of genes biologically defines a subset of schizophrenia
Trastuzumab Deruxtecan-Induced Interstitial Lung Disease/Pneumonitis in ERBB2-Positive Advanced Solid Malignancies: A Systematic Review
Downregulation of miR-204 expression defines a highly aggressive subset of Group 3/Group 4 medulloblastomas
Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancer
Expression of leukosialin (CD43) defines a major intrahepatic T cell subset associated with protective responses in visceral leishmaniasis
miR-1296-5p decreases ERBB2 expression to inhibit the cell proliferation in ERBB2-positive breast cancer
Genetische Analyse des Tyrosinkinase-Rezeptors ErbB2
Genome profiling of ERBB2-amplified breast cancers
Genetische Analyse des Tyrosinkinase-Rezeptors ErbB2
A FERM-adjacent (FA) region defines a subset of the 4.1 superfamily and is a potential regulator of FERM domain function